Zentalis Pharmaceuticals Balance Sheet (2021-2026) | ZNTL

Balance Sheet Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Receivables - Accured (Quarter) 0.26M0.27M0.47M0.42M0.51M0.39M0.88M1.93M3.34M3.15M3.28M3.31M2.94M2.74M2.45M2.15M1.93M2.10M
Assets
Current Assets
Cash & Equivalents (Quarter) 59.71M30.57M55.14M42.55M43.07M36.28M266.56M110.75M28.04M37.62M36.98M41.32M33.90M41.93M37.60M39.07M35.99M31.93M
Receivables - Net (Quarter) 0.00M5.00M
Receivables - Other (Quarter) 2.37M2.35M2.98M3.23M5.87M7.91M
Receivables (Quarter) 2.38M5.00M
Prepaid Assets (Quarter) 10.64M11.67M24.34M22.40M14.56M17.71M18.86M11.63M20.62M14.82M13.23M9.02M14.40M13.77M11.39M7.61M11.41M10.43M
Current Assets (Quarter) 350.77M301.28M467.63M433.89M451.93M410.23M563.93M528.26M496.72M503.81M439.62M400.27M386.07M342.88M311.60M288.30M253.19M218.10M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 8.15M8.48M8.22M8.03M7.71M6.88M6.65M6.39M5.82M5.68M5.34M5.02M4.70M3.25M3.09M2.93M2.77M2.65M
Long-Term Investments (Quarter) 37.49M35.74M30.41M28.04M21.21M18.90M454.88M451.37M389.41M349.93M
Goodwill (Quarter) 3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M
Goodwill & Intangibles (Quarter) 3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M3.74M
Other Non-Current Assets (Quarter) 2.63M2.87M2.63M2.63M2.63M2.63M2.63M2.63M2.68M2.68M2.68M2.63M4.42M2.63M2.63M2.63M2.63M4.09M
Non-Current Assets (Quarter) 103.74M104.39M100.23M95.30M87.38M79.12M57.52M57.45M54.97M53.67M52.06M50.39M44.27M41.14M40.11M38.95M35.78M34.97M
Assets (Quarter) 454.51M405.68M567.86M529.19M539.31M489.34M621.44M585.72M551.69M557.48M491.68M450.66M430.34M384.02M351.71M327.25M288.97M253.07M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 11.59M13.16M12.04M9.82M11.25M12.82M12.30M14.26M14.93M10.50M20.44M8.20M7.44M7.77M3.72M7.03M7.21M7.38M
Payables (Quarter) 11.59M13.16M12.04M9.82M11.25M12.82M12.30M14.26M14.93M10.50M20.44M8.20M7.44M7.77M3.72M7.03M7.21M7.38M
Accumulated Expenses (Quarter) 32.35M30.32M36.59M44.24M45.40M43.54M39.45M44.65M54.44M44.30M46.25M46.67M45.29M41.66M35.30M30.14M29.35M27.86M
Total Current Liabilities (Quarter) 43.94M43.48M48.64M54.06M56.65M56.36M51.76M58.92M69.37M54.80M66.69M54.88M52.73M49.43M39.02M37.17M36.56M35.24M
Non-Current Liabilities
Minority Interest (Quarter) 0.53M0.37M0.33M0.23M0.22M0.18M0.14M0.13M0.11M
Operating Leases (Quarter) 44.46M45.17M44.77M46.36M45.69M43.15M45.35M41.32M40.46M39.58M38.65M37.69M36.71M35.70M34.65M
Non-Current Deferred Tax Liability (Quarter) 1.62M1.55M1.32M1.23M0.85M0.76M10.34M
Other Non-Current Liabilities (Quarter) 1.00M44.98M2.62M1.79M0.50M1.63M1.78M1.29M1.09M1.00M0.85M0.56M0.50M0.50M0.50M0.50M
Total Non-Current Liabilities (Quarter) 89.03M45.03M95.03M100.45M102.67M101.89M97.66M102.18M112.52M97.41M108.01M95.33M92.30M88.08M76.71M73.88M72.26M69.89M
Total Liabilities (Quarter) 90.03M90.01M95.03M100.45M105.29M103.68M98.16M103.82M114.30M98.71M109.10M96.33M93.15M88.64M77.21M74.38M72.76M70.39M
Shareholder's Equity
Common Equity (Quarter) 364.48M315.67M472.82M428.74M434.02M385.67M523.28M481.90M437.28M458.77M382.58M354.33M337.19M295.38M274.50M252.87M216.20M182.68M
Shareholder's Equity (Quarter) 364.48M315.67M472.82M428.74M434.02M385.67M523.28M481.90M437.28M458.77M382.58M354.33M337.19M295.38M274.50M252.87M216.20M182.68M
Liabilities and Shareholders Equity (Quarter) 454.51M405.68M567.86M529.19M539.31M489.34M621.44M585.72M551.69M557.48M491.68M450.66M430.34M384.02M351.71M327.25M288.97M253.07M
Retained Earnings (Quarter) -359.56M-418.64M-1.78M-2.27M-596.37M-659.58M-0.34M-827.64M2.19M-878.49M-966.76M-1006.92M0.56M-1102.67M-1129.55M0.19M0.20M-1226.81M
Treasury Shares (Quarter) 0.27M0.13M949.007.50M5.36M
Shares Outstanding (Quarter) 45.49M45.58M56.97M57.00M59.28M59.44M70.60M70.64M70.77M71.01M71.11M71.15M71.28M71.95M72.14M72.25M69.09M71.16M